Calviri Inc.
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Oct 2021 | $11 M | No. 3 | $10 to $50 million | equity | SEC | |
| Sep 2020 | $2 M | No. 2 | $2 to $10 million | equity | SEC | |
| Dec 2018 | $2 M | No. 1 | Under $2 million | equity, debt | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Calviri Inc. reported revenue of $21,661 for its most recent fiscal year (filed Aug 2024), down from $44,550 the year before.
SEC Form C · Aug 2024
Net loss for the same year: $5.54 million.
SEC Form C · Aug 2024
Calviri Inc. chose not to state its revenue in its newest notice of a funding round (May 2023).
SEC Form D · May 2023
The industry group it chose in its notices: Biotechnology.
SEC Form D · May 2023
In its own words
How the company describes itself to search engines on its website, word for word.
“Calviri | Let's End Cancer. First Dogs, Then People.”
Source: The company's website · as of Nov 15, 2026
Products and services#
No products or services on record: its website does not describe any in structured form (a page that declares itself a product or service), and Wikidata lists none.
Investors#
No investor of Calviri Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 32 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Stephen Albert Johnston | Executive officer | May 2023 |
| Marc J. Wolff | Executive officer | Nov 2021 |
| Jacque J. Sokolov | Director | May 2023 |
| Jeff J. Le Benger | Director | May 2023 |
| Kathryn Albert Sykes | Director | May 2023 |
| Michael J. Chambers | Director | May 2023 |
| Michael J. McCallister | Director | May 2023 |
| Stephen Albert Johnston | Director | May 2023 |
| Marc J. Wolff | Director | Nov 2021 |
| Anna Albert Barker | Director | Mar 2020 |
| George Albert Poste | Director | Mar 2020 |
| Neal Albert Woodbury | Director | Mar 2020 |